Interface between allergy, oncology explored

January 5, 2017

(HealthDay)—The interface between allergic responses and oncology is being explored, which may have implications for treatment, according to a European Academy of Allergy and Clinical Immunology position paper published online Dec. 29 in Allergy.

Noting that studies have reported links between Th2 responses and , including insights into the functions of immunoglobulin E (IgE) antibodies, Erika Jensen-Jarolim, M.D., from the University of Vienna, and colleagues reviewed the current and future translational opportunities and challenges in the field of allergo-oncology. In order to derive novel insights into more effective treatments, expert groups focused on the interface between allergic responses and cancer, with application to , immunomodulation, and IgE-mediated immune responses against cancer.

The researchers note that recent developments include improved understanding of Th2 antibodies, intra-tumoral innate allergy effector cells and mediators, IgE-mediated tumor antigen cross-presentation by , and immunotherapeutic strategies, including vaccines and recombinant antibodies. In addition, they addressed management of allergy in clinical oncology.

"The AllergoOncology field represents an open interdisciplinary science forum where different aspects of the interface between allergy and cancer are systematically addressed and discussed, gaining thereby previously unappreciated insights for cancer immunotherapy," the authors write.

Explore further: When do allergy shots become necessary?

More information: Full Text (subscription or payment may be required)

Related Stories

When do allergy shots become necessary?

April 12, 2016
The beauty of spring is upon us, but as lovely as it may be to look at, it can wreak havoc in your nose, throat and eyes. The higher the pollen count, the greater the misery.

Drug allergy passport advised for patients with hypersensitivity

May 10, 2016
(HealthDay)—A drug allergy passport, providing information on culprit drugs, clinical manifestations, and alternate drugs to prescribe, should be provided to patients with drug hypersensitivity, according to a position ...

Modified proteins as vaccines against peach allergy

January 20, 2014
A research conducted by the Centre for Plant Biotechnology and Genomics (UPM-INIA) and led by Araceli Díaz Perales has studied the allergy to peach, the most common food allergy, and the Pru p 3 protein. As a result of this ...

Food allergy development linked to skin exposure

November 3, 2014
Food allergies are on the rise in the U.S. and other developed countries. In patients, food allergies appear as a variety of symptoms, ranging from mild skin inflammation to severe asthma. Recent studies suggest that contact ...

Early childhood exposure to farm animals and pets modifies immunological responses

December 14, 2015
Exposure to farm animals in early childhood modifies the key allergy-related immunological mechanisms, shows a recent study from the University of Eastern Finland. The study provides new insight into the role of dendritic ...

Recommended for you

Genetic immune deficiency could hold key to severe childhood infections

July 18, 2017
A gene mutation making young children extremely vulnerable to common viruses may represent a new type of immunodeficiency, according to a University of Queensland researcher.

What are the best ways to diagnose and manage asthma?

July 18, 2017
What are the best ways to diagnose and manage asthma in adults? This can be tricky because asthma can stem from several causes and treatment often depends on what is triggering the asthma.

Large multi-ethnic study identifies many new genetic markers for lupus

July 17, 2017
Scientists from an international consortium have identified a large number of new genetic markers that predispose individuals to lupus.

Study finds molecular explanation for struggles of obese asthmatics

July 17, 2017
A large, bouquet-shaped molecule called surfactant protein A, or SP-A, may explain why obese asthma patients have harder-to-treat symptoms than their lean and overweight counterparts, according to a new study led by scientists ...

Team identifies potential cause for lupus

July 14, 2017
Leading rheumatologist and Feinstein Institute for Medical Research Professor Betty Diamond, MD, may have identified a protein as a cause for the adverse reaction of the immune system in patients suffering from lupus. A better ...

Immunosuppression underlies resistance to anti-angiogenic therapy

July 14, 2017
A Massachusetts General Hospital (MGH) research team has identified a novel mechanism behind resistance to angiogenesis inhibitors - drugs that fight cancer by suppressing the formation of new blood vessels. In their report ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.